Cargando…

The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study

INTRODUCTION: Patients with inflammatory bowel disease (IBD) have a high risk of developing extra-intestinal manifestations (EIMs). We aimed to assess the cumulative incidence and clinical course of EIMs in patients treated with Vedolizumab (VDZ) and non-gut selective biologic drugs. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferretti, Francesca, Monico, Maria Camilla, Cannatelli, Rosanna, Carmagnola, Stefania, Lenti, Marco Vincenzo, Di Sabatino, Antonio, Conforti, Francesco, Pastorelli, Luca, Caprioli, Flavio, Bezzio, Cristina, Saibeni, Simone, Mazza, Stefano, Vecchi, Maurizio, Maconi, Giovanni, Ardizzone, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393583/ https://www.ncbi.nlm.nih.gov/pubmed/36004370 http://dx.doi.org/10.3389/fmed.2022.933357

Ejemplares similares

An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
por: Ferretti, Francesca, et al.
Publicado: (2022)

OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
por: Ferretti, F., et al.
Publicado: (2021)

Therapeutic Management of Adults with Inflammatory Bowel Disease and Malignancies: A Clinical Challenge
por: Ferretti, Francesca, et al.
Publicado: (2023)

Ultrasonographic Evaluation of Intestinal Fibrosis and Inflammation in Crohn’s Disease. The State of the Art
por: Ferretti, Francesca, et al.
Publicado: (2021)

Relevance of sonographic parameters for inflammatory bowel disease in children
por: Dell’Era, Alessandra, et al.
Publicado: (2023)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021)

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
por: Maconi, Giovanni, et al.
Publicado: (2021)

Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology–Surgery Team to Include an Infectious Disease Specialist
por: Bezzio, Cristina, et al.
Publicado: (2021)

Dermatological Manifestations in Inflammatory Bowel Diseases
por: Antonelli, Elisabetta, et al.
Publicado: (2021)

Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2023)

SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves
por: Bezzio, Cristina, et al.
Publicado: (2023)

Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
por: Bezzio, Cristina, et al.
Publicado: (2022)

Extra-Intestinal Manifestations of Inflammatory Bowel Disease
por: Sange, Aliya H, et al.
Publicado: (2021)

Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease
por: Vernero, Marta, et al.
Publicado: (2023)

Stem Cell Injection for Complex Refractory Perianal Fistulas in Crohn's Disease: A Single Center Initial Experience
por: Colombo, Francesco, et al.
Publicado: (2022)

Is hypertension an extra‐intestinal manifestation of inflammatory bowel disease?
por: Burisch, Johan
Publicado: (2023)

Endoscopic management of recurrent cholangitis following EUS-guided choledochoduodenostomy
por: Salerno, Raffaele, et al.
Publicado: (2022)

New endoscopic tools in inflammatory bowel disease
por: Nardone, Olga Maria, et al.
Publicado: (2022)

Lung injury as an extra-intestinal manifestation of inflammatory bowel disease
por: Park, Kyung Sik
Publicado: (2016)

How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
por: Ferretti, Francesca, et al.
Publicado: (2021)

Insights into the role of gastrointestinal ultrasound in ulcerative colitis
por: Bezzio, Cristina, et al.
Publicado: (2021)

Tolerability of Bowel Preparation and Colonoscopy in IBD Patients: Results From a Prospective, Single-Center, Case–Control Study
por: Bezzio, Cristina, et al.
Publicado: (2020)

Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT‐P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study
por: Mazza, Stefano, et al.
Publicado: (2021)

Fr100 TELEMEDICINE IN GASTROENTEROLOGY: A STUDY ON FEASIBILITY AND PATIENTS’ TRUST DURING COVID-19 PANDEMIC.
por: Costantino, Andrea, et al.
Publicado: (2021)

Planning phase two for endoscopic units in Northern Italy after the COVID-19 lockdown: An exit strategy with a lot of critical issues and a few opportunities
por: Manes, Gianpiero, et al.
Publicado: (2020)

Is Multiple Sclerosis an Extra-Intestinal Manifestation of Inflammatory Bowel Disease? Food for Thought
por: Dziadkowiec, Karolina N, et al.
Publicado: (2020)

PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY
por: Macaluso, F.S., et al.
Publicado: (2022)

Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis
por: Bezzio, Cristina, et al.
Publicado: (2023)

Abdominal Symptoms and Colonic Diverticula in Marfan’s Syndrome: A Clinical and Ultrasonographic Case Control Study
por: Maconi, Giovanni, et al.
Publicado: (2020)

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2020)

Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?
por: Nardone, Olga Maria, et al.
Publicado: (2019)

Proteomic insights on the metabolism in inflammatory bowel disease
por: Pisani, Laura Francesca, et al.
Publicado: (2020)

OC.06.8 THE EMERGING ROLE OF TELEMEDICINE IN GASTROENTEROLOGY DURING THE COVID-19 PANDEMIC: A STUDY ON ITS FEASIBILITY AND PATIENTS’ TRUST
por: Costantino, A., et al.
Publicado: (2021)

Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect
por: Occhipinti, Vincenzo, et al.
Publicado: (2021)

Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons
por: Tontini, Gian Eugenio, et al.
Publicado: (2021)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease
por: De Nicolò, Amedeo, et al.
Publicado: (2022)

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY
por: Macaluso, F.S., et al.
Publicado: (2023)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease
por: Costantino, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mk8tbgs42ojio3hd94uqnqikq6